English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 33 Help

Selected(0)Clear Items/Page:    Sort:
Red yeast rice ameliorates non-alcoholic fatty liver disease through inhibiting lipid synthesis and NF-κB/NLRP3 inflammasome-mediated hepatic inflammation in mice Journal article
Chinese Medicine (United Kingdom), 2022,Volume: 17,Issue: 1
Authors:  Zou, Jian;  Yan, Chunyan;  Wan, Jian Bo
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/05/13
Lipid synthesis  NAFLD  NF-κB  NLRP3 inflammasome  Red yeast rice  
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review Journal article
Hepatology International, 2022,Volume: 16,Issue: 1,Page: 27-37
Authors:  Zou, Huimin;  Ge, Ying;  Lei, Qing;  Ung, Carolina Oi Lam;  Ruan, Zhen;  Lai, Yunfeng;  Yao, Dongning;  Hu, Hao
Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date：2022/03/04
Disease Burden  Epidemiology  Non-alcoholic Steatohepatitis  Systematic Review  
Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy Journal article
Chinese Medicine (United Kingdom), 2021,Volume: 16,Issue: 1
Authors:  Liu, Jingxin;  Zhang, Tian;  Zhu, Jianzhong;  Ruan, Shuangchen;  Li, Rongsong;  Guo, Bing;  Lin, Ligen
Favorite |  | TC[WOS]:0 TC[Scopus]:1 | Submit date：2021/12/08
Hepatocytes  Honokiol  Lipid Accumulation  Lipolysis  Lipophagy  Sirt3  
Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat Journal article
Chinese Medicine (United Kingdom), 2021,Volume: 16,Issue: 1
Authors:  Lan, Qingping;  Ren, Zhitao;  Chen, Yan;  Cui, Guozhen;  Choi, I. Cheong;  Ung, Carolina Oi Lam;  Yu, Hon Ho;  Lee, Simon Ming Yuen
Favorite |  | TC[WOS]:5 TC[Scopus]:5 | Submit date：2021/12/09
Fibrosis  Hscs Reprogramming  Inflammation  Mapk Pathway  Methionine-choline Deficient Diet  Non-alcoholic Fatty Liver Disease  Non-alcoholic Steatohepatitis  P-p65  Ppar-γ  Qushihuayu  Traditional Chinese Medicine  
Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism Journal article
Journal of Advanced Research, 2021,Volume: 34,Page: 109-122
Authors:  Wang, Songsong;  Sheng, Feiya;  Zou, Liang;  Xiao, Jianbo;  Li, Peng
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date：2022/01/14
Bile Acid Metabolism  Cholesterol Metabolism  Hyperoside  Label-free Proteomics  Nafld  Targeted Metabolomics  
β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats Journal article
International Immunopharmacology, 2021,Volume: 98
Authors:  Luo, Huijuan;  Xu, Nan;  Wu, Jiazhen;  Gan, Yuxuan;  Chen, Liping;  Guan, Fengkun;  Li, Mengyao;  Li, Yucui;  Chen, Jiannan;  Su, Ziren;  Liu, Yuhong
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2021/12/08
Histanoxia  Non-alcoholic Steatohepatitis  Oxidative Stress  Soluble Cd36  Β-patchoulene  
Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats Journal article
Phytomedicine, 2021,Volume: 85
Authors:  Li, Qiao Ping;  Dou, Yao Xing;  Huang, Zi Wei;  Chen, Han Bin;  Li, Yu Cui;  Chen, Jian Nan;  Liu, Yu Hong;  Huang, Xiao Qi;  Zeng, Hui Fang;  Yang, Xiao Bo;  Su, Zi Ren;  Xie, Jian Hui
Favorite |  | TC[WOS]:4 TC[Scopus]:4 | Submit date：2021/12/07
Ampk Signaling Pathway  Berberine  Insulin Signaling Pathway  Non-alcoholic Fatty Liver Disease  Obesity  Oxyberberine  
β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway Journal article
Biomedicine and Pharmacotherapy, 2021,Volume: 134
Authors:  Xu, Nan;  Luo, Huijuan;  Li, Minyao;  Wu, Jiazhen;  Wu, Xue;  Chen, Liping;  Gan, Yuxuan;  Guan, Fengkun;  Li, Mengyao;  Su, Ziren;  Chen, Jiannan;  Liu, Yuhong
Favorite |  | TC[WOS]:2 TC[Scopus]:4 | Submit date：2021/12/07
Amp-activated Protein Kinase  Hepatic Steatosis  Non-alcoholic Fatty Liver Disease  Pogostemon Cablin  Β-patchoulene  
Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19 Other
2021-02-01
Authors:  Ji, Dong;  Zhang, Mingjie;  Qin, Enqiang;  Zhang, Lunqing;  Xu, Jing;  Wang, Yudong;  Cheng, Gregory;  Wang, Feng;  Lau, George
Favorite |  | TC[WOS]:10 TC[Scopus]:9 | Submit date：2021/12/07
Covid-19  Deep Vein Thrombosis  Non-alcoholic Fatty Liver Disease  
Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials Journal article
Chinese Medicine (United Kingdom), 2021,Volume: 16,Issue: 1
Authors:  Liang,Zuanji;  Chen,Xianwen;  Shi,Junnan;  Hu,Hao;  Xue,Yan;  Ung,Carolina Oi Lam
Favorite |  | TC[WOS]:6 TC[Scopus]:6 | Submit date：2021/03/01
Consort-chm  Non-alcoholic Fatty Liver Disease  Randomized Clinical Trial  Rct  Risk Of Bias  Traditional Chinese Medicine